These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29431205)

  • 1. Non-IgE mediated mast cell activation.
    Redegeld FA; Yu Y; Kumari S; Charles N; Blank U
    Immunol Rev; 2018 Mar; 282(1):87-113. PubMed ID: 29431205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells as effector cells of innate immunity and regulators of adaptive immunity.
    Cardamone C; Parente R; Feo GD; Triggiani M
    Immunol Lett; 2016 Oct; 178():10-4. PubMed ID: 27393494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell-derived cytokine expression induced via Fc receptors and Toll-like receptors.
    Okayama Y
    Chem Immunol Allergy; 2005; 87():101-110. PubMed ID: 16107766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly changing perspectives about mast cells at mucosal surfaces.
    Vliagoftis H; Befus AD
    Immunol Rev; 2005 Aug; 206():190-203. PubMed ID: 16048550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern Recognition Receptors and Control of Innate Immunity: Role of Nucleic Acids.
    Fischer S
    Curr Pharm Biotechnol; 2018; 19(15):1203-1209. PubMed ID: 30636600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the threshold-Signals and mechanisms of mast cell priming.
    Halova I; Rönnberg E; Draberova L; Vliagoftis H; Nilsson GP; Draber P
    Immunol Rev; 2018 Mar; 282(1):73-86. PubMed ID: 29431203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of LXRs using the synthetic agonist GW3965 represses the production of pro-inflammatory cytokines by murine mast cells.
    Nunomura S; Okayama Y; Matsumoto K; Hashimoto N; Endo-Umeda K; Terui T; Makishima M; Ra C
    Allergol Int; 2015 Sep; 64 Suppl():S11-7. PubMed ID: 26344074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-mediated mast cell activation: ligand similarities for receptor recognition and protease-induced regulation.
    Lu L; Kulka M; Unsworth LD
    J Leukoc Biol; 2017 Aug; 102(2):237-251. PubMed ID: 28606938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mast cell: an antenna of the microenvironment that directs the immune response.
    Frossi B; De Carli M; Pucillo C
    J Leukoc Biol; 2004 Apr; 75(4):579-85. PubMed ID: 14726495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-dependent transition of IgE to a detergent-insoluble form is associated with reduced IgE receptor-dependent secretion from RBL-2H3 mast cells.
    Seagrave J; Oliver JM
    J Cell Physiol; 1990 Jul; 144(1):128-36. PubMed ID: 2142164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
    Daëron M; Malbec O; Latour S; Arock M; Fridman WH
    J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology of urticaria].
    Nosbaum A; Augey F; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2014 Nov; 141 Suppl 3():S559-64. PubMed ID: 25539676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid potentiates inflammatory cytokines in human mast cells: identification of mast cells as prominent constituents of the skin retinoid network.
    Babina M; Guhl S; Motakis E; Artuc M; Hazzan T; Worm M; Forrest AR; Zuberbier T
    Mol Cell Endocrinol; 2015 May; 406():49-59. PubMed ID: 25725371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-IgE mediated mast cell activation.
    Yu Y; Blokhuis BR; Garssen J; Redegeld FA
    Eur J Pharmacol; 2016 May; 778():33-43. PubMed ID: 26164792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoglobulin E-Toll-like receptor network.
    Novak N; Bieber T; Peng WM
    Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses.
    Frossi B; Mion F; Tripodo C; Colombo MP; Pucillo CE
    Trends Immunol; 2017 Sep; 38(9):648-656. PubMed ID: 28462845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
    Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
    Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mast cells and basophils-How are they similar how are they different?
    Varricchi G; Raap U; Rivellese F; Marone G; Gibbs BF
    Immunol Rev; 2018 Mar; 282(1):8-34. PubMed ID: 29431214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low affinity receptor for IgE (CD23) in human: a multifunctional receptor/cytokine?
    Dugas B; Mencia-Huerta JM; Braquet P
    Eur Cytokine Netw; 1992; 3(1):35-41. PubMed ID: 1533799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.